Mississippi Voters Legalize Medical Marijuana

Washington, D.C. - November 4, 2020 (Investorideas.com Newswire) Mississippi voters have approved a constitutional ballot initiative to establish a medical marijuana program for patients with debilitating conditions. Mississippi becomes the 36th state to enact a medical marijuana law.

"It is great to see that the tides of change are continuing to flow across the country and now they have come to Mississippi," said Steve Hawkins, executive director of the Marijuana Policy Project, which was founded in 1995 and has played a central role in eight state-level legalization victories over the past eight years. "As we saw in Utah in 2018, and as we see in Mississippi this year, medical marijuana can pass in any state in the country."

Mississippi is one of two states, along with South Dakota, that approved medical marijuana ballot initiatives this November. South Dakota also voted on legalizing marijuana for adults 21 and over, along with Arizona, New Jersey, and Montana. The initiatives in New Jersey and Arizona were approved with strong margins by voters earlier tonight. Advocates are awaiting final results in Montana and South Dakota.

Heading into Election Day, 34 states had legalized medical marijuana, and 11 states had legalized marijuana for adults 21 and over.

About MPP:

The Marijuana Policy Project is the nation's leading cannabis policy organization. It has been advocating for federal cannabis reform since its founding in 1995, and it has played a leading role in the majority of state-level cannabis victories over the past two decades. For more information, visit https://www.mpp.org.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Buy a cannabis guest post on Investorideas.com